Gilead Sciences, Inc. (GILD) Shares Bought by Foundry Partners LLC

The company has a market capitalization of $107.83 billion, a P/E ratio of 8.97 and a beta of 1.14. Moreover, Vanguard Group has 0% invested in CSP Inc. About shares traded. Old Line Bancshares, Inc. CSP Inc. (NASDAQ:CSPI) has risen 49.80% since October 11, 2016 and is uptrending. It has outperformed by 40.33% the S&P500.

The legal version of this article can be viewed at https://stocknewstimes.com/2017/10/12/arizona-state-retirement-system-increases-stake-in-gilead-sciences-inc-gild.html. Chilton Capital Management Llc sold 56,490 shares as Gilead Sciences Inc (GILD)'s stock declined 8.05%. Linscomb & Williams Inc. now owns 5,275 shares of the biopharmaceutical company's stock valued at $358,000 after acquiring an additional 154 shares during the last quarter. Gilead Sciences now has $108.40B valuation. Investment Centers of America Inc. now owns 29,064 shares of the biopharmaceutical company's stock valued at $1,979,000 after acquiring an additional 1,958 shares in the last quarter. The shares were sold at an average price of $75.88, for a total value of $1,138,200.00. It has underperformed by 38.50% the S&P500.

Since May 1, 2017, it had 0 insider buys, and 5 insider sales for $11.13 million activity. Natixis stated it has 0.59% in Gilead Sciences, Inc. Shares for $325,114 were sold by Alton Gregg H. Shares for $4.78 million were sold by MARTIN JOHN C.

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 18 have Buy rating, 0 Sell and 12 Hold. Therefore 21% are positive. U.S. Silica had 71 analyst reports since July 30, 2015 according to SRatingsIntel. (NASDAQ:GILD) earned "Buy" rating by Gabelli on Wednesday, June 1. The stock of U.S. Silica Holdings Inc (NYSE:SLCA) has "Hold" rating given on Friday, February 26 by Jefferies. The stock has "Outperform" rating by Credit Suisse on Wednesday, September 14. $4.78M worth of Gilead Sciences, Inc. The firm has "Buy" rating by Mizuho given on Wednesday, October 26. The rating was maintained by Oppenheimer with "Buy" on Thursday, August 10. The company was maintained on Monday, August 28 by Maxim Group. Investment Centers of America Inc. lifted its position in Gilead Sciences by 7.2% in the 1st quarter. The stock has "Hold" rating by RBC Capital Markets on Sunday, September 17.

Investors sentiment decreased to 0.5 in 2017 Q2. 217.98 million shares or 0.25% less from 218.52 million shares in 2017Q1 were reported. 0 funds opened positions while 3 raised stakes. 938.32 million shares or 0.11% more from 937.32 million shares in 2017Q1 were reported. Trust Communication Of Vermont accumulated 41,579 shares. Hamilton Point Inv Advisors has invested 0.91% in Gilead Sciences, Inc. Cantab Prtn Llp reported 18,687 shares. Qci Asset Mngmt stated it has 0.01% of its portfolio in Gilead Sciences, Inc. It also upped Mylan N V Shs Euro (NASDAQ:MYL) stake by 21,680 shares and now owns 53,986 shares.

Investors are a little more bearish on Gilead Sciences, Inc. if you consider the change in short interest. (NASDAQ:GILD). 24,760 were reported by Maverick Capital.

Gilead Sciences, Inc.is a research biopharmaceutical firm that discovers, develops and commercializes medicines in areas of unmet medical need. Zacks Investment Research cut Gilead Sciences from a "buy" rating to a "hold" rating in a research note on Monday, September 11th. For GILD, the company now has $8.71 Billion of cash on the books. Oakwood Management Lc Ca has invested 0.88% in Gilead Sciences, Inc. Meyer Handelman Co. now owns 380,900 shares of the biopharmaceutical company's stock worth $25,871,000 after purchasing an additional 9,900 shares during the last quarter. Nationwide Fund Advsrs, a Pennsylvania-based fund reported 31,915 shares. 318,705 were reported by Zwj Invest Counsel. Moreover, Commonwealth Fincl Bank Of Aus has 0.01% invested in Spirit AeroSystems Holdings, Inc. (NASDAQ:GILD) for 5,251 shares. Dupont Capital, Delaware-based fund reported 99,770 shares. Fagan Associate accumulated 1.22% or 33,075 shares. Gilead Sciences's dividend payout ratio (DPR) is presently 22.58%. Gilead Sciences had a net margin of 42.90% and a return on equity of 66.07%. The ex-dividend date was Thursday, September 14th. Nikko Asset Management Americas Inc. lifted its stake in Gilead Sciences by 67.2% during the first quarter. (NASDAQ:GILD) or 5,000 shares. They expect $2.07 earnings per share, down 23.33% or $0.63 from last year's $2.7 per share. CI's profit will be $590.43 million for 20.04 P/E if the $2.34 EPS becomes a reality. After $2.51 actual EPS reported by Gilead Sciences, Inc. for the previous quarter, Wall Street now forecasts -17.53% negative EPS growth.

Boston Llc has 390,220 shares. The company has an average rating of "Buy" and an average target price of $85.86. It also upped Valeant Pharmaceuticals Intern Com (NYSE:VRX) stake by 45,000 shares and now owns 245,000 shares.

Investors sentiment is 1.33 in Q2 2017. Its up 0.08, from 0.99 in 2017Q1. Vantage Advsr Ltd holds 712 shares. 168,486 shares or 83.25% less from 1.01 million shares in 2017Q1 were reported. Valley Natl Advisers Inc holds 316 shares. Truepoint holds 0.03% or 4,221 shares. They expect $2.07 earnings per share, down 23.33% or $0.63 from last year's $2.7 per share. Knoll Capital Management Lp owns 461,538 shares or 2.15% of their U.S. portfolio. About 1.92 million shares traded. Independence Com has invested 0.28% in Centurylink Inc (NYSE:CTL). Federated Investors Inc (NYSE:FII) was raised too. (NYSE:MRK). Peak Asset Management Limited Liability Co owns 15,537 shares or 0.37% of their USA portfolio. 21,740 were accumulated by Martingale Asset Mgmt Ltd Partnership. Kwmg Lc reported 0.54% stake. Tompkins Financial Corp has 0% invested in Centurylink Inc (NYSE:CTL). (NYSE:SPR). Koch Indus owns 532,994 shares. Hedge funds and other institutional investors own 73.98% of the company's stock. Loomis Sayles & Lp stated it has 0% in Spirit AeroSystems Holdings, Inc.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related Articles

  • No late Christmas Eve kick off for Newcastle, West Ham

    No late Christmas Eve kick off for Newcastle, West Ham

    A Christmas Eve Premier League fixture is also likely to put extra strain on emergency services, and make travel hard for fans. Any game played on Christmas Eve is now expected to be scheduled for a 12pm or 2pm kickoff.
    Harvey Weinstein: Matt Damon denies 'killing' 2004 story

    Harvey Weinstein: Matt Damon denies 'killing' 2004 story

    Hemsworth said he brought his Thor: Ragnarok co-star Mark Ruffalo and director Taika Waititi with him to the show. Immediately trying to have the camera ignore Damon, Kimmel yelled, "It's the mighty Thor , not the mighty bore! ".
    Royal Mail wins High court injunction preventing strike action

    Royal Mail wins High court injunction preventing strike action

    Staff were also considering action during the Black Friday retail sales event next month or during the festive season. The last mass industrial action among postal workers was in 2009.
  • Twitter reverses course, will allow Blackburn campaign to promote pro-life ad

    Twitter reverses course, will allow Blackburn campaign to promote pro-life ad

    Profiting from the sale of human body parts - including those of the unborn - is illegal in the United States. Blackburn's campaign ad to be promoted on our ads platform", The Associated Press reported.

    Magical McClean keeps Republic on the road to Russia

    Alongside Maguire in the Ireland squad is PNE winger Daryl Horgan, with North End 'keeper Chris Maxwell in the Wales camp. And a win on Monday could take them to their first World Cup since 1958. "I think we will go for it, both teams".

    Which Stocks To Invest? - Outfront Media Inc. (OUT), Regeneron Pharmaceuticals, Inc. (REGN)

    The investment professionals in our partner's database now have: 71.53 million shares, up from 70.55 million shares in 2017Q1. Investors are a little more bearish on Regeneron Pharmaceuticals, Inc. of late if you consider the change in short interest.
  • IAF commandos martyred, two Lashkar terrorists killed

    IAF commandos martyred, two Lashkar terrorists killed

    They were injured in the exchange of fire with the terrorists and evacuated to 92 base hospital, where they succumbed to injuries. The Indian army camp was attacked by grenades thrown by the attackers. "It is a big success for the security forces", Vaid said.
    Shopping With Google Assistant Coming Soon, Target Added to Google Express

    Shopping With Google Assistant Coming Soon, Target Added to Google Express

    To be sure, the penetration of Google Home devices in American households is still less than that of Amazon's Echo devices. But it has plans to grow in other areas with voice-enabled shopping, like apparel, home and beauty, the company said.

    Aerie Pharmaceuticals Scores Relative Strength Rating Upgrade

    On a one to five ratings scale where 1.0 indicates a Strong Buy, 2.0 indicates a Buy, 3.0 a Hold, 4.0 a Sell and 5.0 a Stong Sell. Also, there are 1 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1.5 average brokerage recommendation.
  • This McLaren MSO R is a two-off supercar special

    This McLaren MSO R is a two-off supercar special

    Incredible how bright pink can make a carbon central stripe, giant rear wing and dive planes look quite sensible. Inside, black Alcantara covers the dashboard, contrasted by red bucket seats complete with MSO R embroidery.

    Hartford Financial Services Gro (NYSE:HGH) Sees Significantly Lower Trading Volume

    The market capitalization (Stock Price Multiply by Total Number of Outstanding Shares) for the company is reported at $20.32B. Following the acquisition, the director now owns 5,755 shares of the company's stock, valued at approximately $286,138.60.
    Netflix's (NFLX) Buy Rating Reiterated at MKM Partners

    Netflix's (NFLX) Buy Rating Reiterated at MKM Partners

    The company had revenue of $2.79 billion during the quarter, compared to analysts' expectations of $2.76 billion. Telsey Advisory downgraded the shares of CBS in report on Thursday, September 22 to "Market Perform" rating.